DOCSLIB.ORG

Curriculum Vitae: David W

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Curriculum Vitae: David W David W. Hein CV, September 2021 CURRICULUM VITAE: DAVID W. HEIN Peter K. Knoefel Endowed Chair of Pharmacology and Toxicology Professor and Chair, Department of Pharmacology and Toxicology Distinguished University Scholar Director, University of Louisville NIEHS Environmental Health Sciences Training Program Director, University of Louisville NCI Cancer Education Program University of Louisville Orchid ID: orcid.org/0000-0003-3261-9775 Executive Summary Dr. Hein serves as Peter K. Knoefel Endowed Chair of Pharmacology, Professor and Chairman of the Department of Pharmacology & Toxicology, and Distinguished University Scholar at the University of Louisville. He leads three National Institutes of Health-funded training programs: University of Louisville Cancer Education Program funded by the National Cancer Institute; University of Louisville pre- and post- doctoral training program in environmental health sciences funded by the National Institutes of Environmental Health Sciences (NIEHS); and University of Louisville Superfund Research Center Training Core funded by NIEHS. Dr. Hein also serves as Deputy Director and Director of Faculty Career Development for the University of Louisville Hepatobiology and Toxicology COBRE funded by the National Institute of General Medical Sciences. From 2009-2017 he served as Associate Provost for Strategic Planning and Vice Provost for Academic Strategy. Numerous students have completed thesis and dissertation research training in his laboratory and he contributes towards instruction of undergraduate, graduate and health professional students. Prior to recruitment to the University of Louisville, Dr. Hein served as founding director of the National Institutes of Health-funded Minority Biomedical Research Support Program at Morehouse School of Medicine, chair of the Departments of Pharmacology & Toxicology at Morehouse School of Medicine and the University of North Dakota School of Medicine and Health Sciences. He has served as reviewer of grant proposals for the National Institutes of Health and other funding agencies and a consultant to numerous companies across the USA and the world. Dr. Hein’s research program includes studies of the molecular epidemiology of cancer susceptibility, pharmacogenetics, genomics, personalized medicine, and functional genomics. The research in molecular epidemiology identifies individuals genetically susceptible to the development of cancer and other diseases from environmental and occupational chemicals in order to focus treatment and prevention public health strategies on those at greatest risk. The research in pharmacogenetics/genomics and personalized/precision medicine improves our understanding of the genetic causes for drug failure and/or drug toxicity in order to optimize clinical drug therapy for each individual patient. The research in functional genomics improves understanding of the mechanistic and clinical consequences of genetic variation in the biotransformation of carcinogens and drugs. The research program has been funded continuously since 1983 by over 75 grants and contracts from the National Institutes of Health and other federal and private foundations and industry. He has coauthored over 250 peer-reviewed journal articles and book chapters, 75 gene sequences, and over 650 abstracts and 16,000 citations (h-index=65) in the scientific literature. He has presented about 150 invited research seminars in Australia, Austria, Canada, China, Czech Republic, Egypt, France, Germany, Greece, Italy, Norway, Switzerland, the United Kingdom and across the USA. Dr. Hein was appointed as Chester Fritz Distinguished Professor at the University of North Dakota, has received outstanding teaching awards awarded by the medical school class at both Morehouse School of Medicine and the University of North Dakota, the President's Faculty Achievement Award at Morehouse School of Medicine, the Thomas J. Clifford Faculty Achievement Award for Excellence in Research and 1 David W. Hein CV, September 2021 the Burlington Northern Faculty Achievement Award for Excellence in Teaching, Research, and Creative Activity both from the University of North Dakota, an Outstanding Alumnus Award from the University of Michigan, the President's Award from the University of Wisconsin-Eau Claire, and President's Outstanding Scholarship, Research and Creative Activity Awards in Basic/Applied Sciences and Career Achievement from the University of Louisville. He presented the Astor Visiting Lectureship at the University of Oxford (UK) and served as a Visiting Professor at the University of Paris Diderot. He has been elected to membership in the Academy of Pharmacology Educators of the American Society for Pharmacology and Experimental Therapeutics. As King David described in his prayer, honors are provided by the grace of our God. Office: Kosair Charities CTR – Room 303 University of Louisville Health Sciences Center 505 South Hancock Street Louisville, KY 40202-1617 Website: http://louisville.edu/faculty/dwhein01 Telephone: (502) 852-6252 E-Mail: [email protected] Citizenship: United States of America EDUCATION 1969-1973 Wisconsin Lutheran High School Milwaukee, Wisconsin 1973-1977 University of Wisconsin-Eau Claire B.S. (Chemistry) 1977-1982 University of Michigan Ph.D. (Pharmacology) ADMINISTRATIVE APPOINTMENTS (University of Louisville) 1997 – Chair, Department of Pharmacology and Toxicology 2004 – 2016; 2018 – Director (Founding), NIEHS Environmental Health Sciences Training Program 2011 – Director, University of Louisville NCI Cancer Education Program 2018 – Leader, University of Louisville Superfund Research Center Training Core 2015 – 2017 Vice Provost for Academic Strategy 2009 – 2015 Associate Provost for Strategic Planning 2011 – 2012 Interim Chair, Department of Microbiology and Immunology 2 David W. Hein CV, September 2021 2008 – 2009 Special Assistant to the Provost for Strategic Planning 2003 – 2009 Leader, Cancer Prevention and Control Program, Brown Cancer Center 2002 – 2003 Leader, Molecular Epidemiology and Prevention Group, Brown Cancer Center 1999 – 2003 Interim Director, Center for Genetics and Molecular Medicine ADMINISTRATIVE APPOINTMENTS (University of North Dakota) 1989 – 1997 Chair, Department of Pharmacology and Toxicology University of North Dakota School of Medicine and Health Sciences Grand Forks, North Dakota 1991 – 1997 Director, Graduate Program in Pharmacology and Toxicology University of North Dakota School of Medicine and Health Sciences 1989 – 1997 Director, Medical Pharmacology I and II courses for Medical Students University of North Dakota School of Medicine and Health Sciences 1992 – 1994 Director, Biomedical Research Support Program University of North Dakota School of Medicine and Health Sciences ADMINISTRATIVE APPOINTMENTS (Morehouse School of Medicine) 1985 – 1989 Chair, Department of Pharmacology Morehouse School of Medicine, Atlanta, Georgia 1986 – 1989 Director (Founding), Minority Biomedical Research Program Morehouse School of Medicine 1983 – 1985 Interim Chair, Department of Pharmacology Morehouse School of Medicine FACULTY APPOINTMENTS 1997 – Professor of Pharmacology and Toxicology (Tenured); Graduate Faculty University of Louisville 1997 – Distinguished University Scholar University of Louisville 2010 – Professor of Medicine (Hematology/Oncology; secondary appointment) University of Louisville School of Medicine 2017 – Member, University of Louisville Superfund Research Center 2018 – Member, Christina L Brown Envirome Institute, University of Louisville 3 David W. Hein CV, September 2021 2020 – Member, Center for Integrated Environmental Health Sciences University of Louisville 1999 – Senior Member, Brown Cancer Center, University of Louisville 1997 – Member, Center for Environmental and Occupational Health Sciences University of Louisville 2007– 2012 Investigator, Center for Environmental Genomics and Integrative Biology University of Louisville 2003 – 2009 Investigator, Center for Environmental Cardiology, University of Louisville 1999 – 2016 Member, Birth Defects Center, University of Louisville 1997 – 2018 Member, Center for Genetics and Molecular Medicine, University of Louisville 1997 – 1999 Distinguished Visiting Professor University of North Dakota School of Medicine and Health Sciences 1993 – 1997 Chester Fritz Distinguished Professor University of North Dakota School of Medicine and Health Sciences 1989 – 1997 Professor (Tenured), Department of Pharmacology and Toxicology University of North Dakota School of Medicine and Health Sciences 1989 – 1994 Adjunct Associate Professor, Department of Chemistry Georgia State University 1989 Professor, Department of Pharmacology Morehouse School of Medicine 1985 – 1989 Associate Professor, Department of Pharmacology, Morehouse School of Medicine 1986 – 1989 Adjunct Assistant Professor, Department of Pharmacology Emory University School of Medicine 1983 – 1989 Graduate Faculty, Department of Biology (Clark)-Atlanta University 1982 – 1985 Assistant Professor, Department of Pharmacology Morehouse School of Medicine 1980 – 1981 Biology Teacher, Huron Valley Lutheran High School 4 David W. Hein CV, September 2021 HONORS • Peter K. Knoefel Endowed Chair of Pharmacology and Toxicology, University of Louisville • Distinguished University Scholar, University of Louisville • Outstanding Alumnus Award, Department of Pharmacology, University of Michigan • President’s Award, University of Wisconsin-Eau Claire • Astor Visiting Lectureship, University of Oxford • President’s Outstanding
Load more

Recommended publications
  • Information Directory
    LTDI INFORMATION DIRECTORY 10th Edition, March 1998 Learning Technology Dissemination Initiative Edited by Phil Barker with the help of other members of the 1997/98 LTDI team A directory of initiatives, organisations, individuals and resources related to communication and information technology used for learning and teaching in Scottish Higher Education. The Learning Technology Dissemination Initiative is funded by the Scottish Higher Education Funding Council LTDI Information Directory 1st published 1994 10th edition Mar 1998 ISBN 0 9528731 2 5 Acknowledgements This edition was edited by Phil Barker helped by Nora Mogey and Jen Harvey. LTDI would like to thank those people and initiatives who have provided us with the information in this directory, given us permission to copy their own information sources and helped check for errors. © LTDI and the original information providers. Whilst every effort has been made to ensure the accuracy of the information in this directory, LTDI wishes to emphasise that the contents are subject to change from time to time. LTDI can not accept any liability for any errors which remain. Please notify us of any factual errors, for correction in the next edition; other suggested amendments are also welcome. If you would like further copies of this directory, please contact the LTDI. A version of this directory, and other LTDI publications are available on the World Wide Web at URL: http://www.icbl.hw.ac.uk/ltdi/ltdi-pub.htm Learning Technology Dissemination Initiative Tel.: 0131 451 3280 Institute for Computer
    [Show full text]
  • Montgomery Bucks Dental Society Distinguished Speaker Series
    Montgomery Bucks Dental Society Distinguished Speaker Series Monday, November 7, 2016 Normandy Farms Rt. 202 and Morris Rd, Blue Bell, PA Dr. Denis Kinane Presents Basis and Consequences of Periodontal Disease Susceptibility COURSE DESCRIPTION This talk will begin by addressing the host responses to the microbial biofilm in periodontitis and peri-implantitis and discuss variable susceptibility to the subgingival dental plaque. The host response to infection draws upon the innate, inflammatory and adaptive immune systems, whose role is to provide the appropriate response to the offending microorganisms. In some cases, this will be little or no response when encountering ‘commensals’, and in other cases a gradated response depending very much on the host’s own determination of the pathogenic nature of the microbial insult: and herein lies the root of variation in host responses that govern individual susceptibility. In some individuals and with some bacteria this will be an innate- only response, others will need to invoke the inflammatory response, and yet others will require the adaptive immune response – be it cellular, humoral or both – to reduce or remove the challenge from the microbes. Of course these responses would be somewhat easier to predict with a single pathogen challenge, and become infinitely more complex as the biofilm increases in complexity. Oral infections, in particular 1 gingival inflammation, originate from not just one but many bacterial species. This polymicrobial infection may result in chronic inflammation in some subjects but not in others due to genetic variation among humans. In addition. the local chronic inflammatory lesions around teeth and implants may have systemic impact and thus therapy for oral diseases is considered to have beneficial effects on general or systemic health.
    [Show full text]
  • Program Code Listing Thursday, March 07, 2013
    Program Code Listing Thursday, March 07, 2013 PROGRAM DESCRIPTION STAT 00000 Default ActiveUS 0000A Grant -02 Active 0000B Grant - 05 Active 0000C Grant-11 Active 0000D Grant - 14 Active 0000E Grant - 18 Active 0000F Grant - 20 Active 0000G Budget program - Fin Aid Grant Active 0000H Grant-0000H Active 0000J Grant - 23 Active 0000K Grant - 26 Active 0000L Grant - 29 Active 0000M Grant - 35 Active 0000N Grant - 50 Active 0000P Grant - 56F Active 0000Q Grant - 59 Active 00100 Net Payroll Active 00200 Liability Default Active 00201 Instruction Default Active 00202 Research Default Active 00203 Public Service Default Active 00204 Academic Support Default Active 00205 Student Services Default Active 00206 Institutional Support Default Active 00207 Operations & Maint Default Active 00208 Financial Aid Default Active 00212 Auxiliary Default Active 00213 Service Center Default Active 00214 Athletic Default Active 00245 Default - Other Post Em Bnfts Active 00246 Investment Default Active 00272 Tuition Default Active 00279 State Approp Default Active 00299 General & Admin Default Active 00300 Asset Mgmt Default Active 00301 Asset Mgmt Default - Component Active 01001 Office Of President Active 01002 Univ-Wide Special Events Active 01003 Univ Counsel Office Active 01004 Univ Faculty Senate Active 01005 Audit Services Active 01006 Acad Svcs For Ath Active 01007 VP Finance Active Page 1 of 192 PROGRAM DESCRIPTION STAT 01008 Office Of The Provost ActiveUS 01009 Sacs Review Active 01010 Cultural Center Active 01012 Inst of Int'l Development Active 01013
    [Show full text]
  • A Back-To-Work Guide for Business Foreword
    A back-to-work guide for business Foreword. Welcome to our COVID-19 back-to-work guide designed to help you understand how best to return your employees to the office safely once the Government gives the green light. We have created this step-by-step guide using the experience we have gained from a range of different private sector organisations over the past year. Our aim is simple: to enable you to provide the safest possible environment for every employee and feel reassured that they can return to the office. Many people remain rightly anxious about the threat of COVID-19 for their own health as well as for family and friends. That is no surprise. Over the past year, we have all seen the tragic rise in the numbers of people losing their lives or being hospitalised as a result of catching COVID-19. Our research, conducted by the independent pollster Yonder, found many employees are concerned about returning to the office. 38% of employees are expecting any return to be entirely voluntary; 48% expect their employers to organise regular COVID-19 testing before they come back; and 22% don’t expect to return until they have been vaccinated. This guide is designed to enable you to reassure the people on whom the future success of your business depends that you have a plan that addresses their genuine concerns. Until the threat of COVID-19 has been eliminated completely, what is clear is that gold standard PCR testing will play a critical part of any back-to-work programme.
    [Show full text]
  • Opinion on Hyrodogen Peroxide in Tooth Whitening Products
    Dear Sir/Madam, I wish to supply the following comment relevant to: SCCP Preliminary Opinion on Hydrogen Peroxide in Tooth Whitening Products 08 December 2004 Regarding 3.3.13.1 Effects of concern "particular care should be taken in administering bleaching agents to patients with gingivitis (or) periodontal disease" * The primary etiological factor in gingivitis and periodontitis is microbial dental plaque: hydrogen peroxide has potential to provide benefit in these conditions through its well-established antimicrobial effect. * Numerous studies have shown that hydrogen peroxide at levels of 1.5-3% in oral hygiene products has beneficial effects in reducing plaque and gingivitis, with no adverse soft tissue changes, even in prolonged use (up to 6 years, as reviewed by Walsh LJ; 2000, Aust Dent J, 45:257-269). * 1% hydrogen peroxide has also been used as adjunctive treatment for periodontitis, applied subgingivally as irrigation. While systematic review of the evidence shows no additional benefit of this treatment over mechanical debridement alone, there is no indication that use of exogenous hydrogen peroxide at this concentration exacerbates periodontal destruction (Hallmon and Rees 2003, Ann Periodontol 8(1): 99-114) and case reports supporting long- term use are still being published (Kawamura et al. 2004, Aust Dent J 49(1): 40-44). * While higher concentrations of hydrogen peroxide might constitute a potential hazard to periodontal tissue, the risk would appear to be low, considering that: * product design and instructions aim to avoid
    [Show full text]
  • Penn Dental Journal
    Penn Dental Journal For the University of Pennsylvania School of Dental Medicine Community / Fall 2012 Growing a World-Class Faculty: Three New Recruits Bring Depth of Clinical, Research Expertise | page 2 Faculty Perspective: Oral Cancer Screening | page 7 | Facilities Update, Master Plan Spotlight | page 8 Answering the Call to Higher Education: Alumni in Academia | page 10 Honor Roll: 2011 –12 Donors | page 29 in this issue Features 2 Growing a World-Class Faculty Penn Dental Journal by katherine unger baillie Vol. 9, No. 1 7 Faculty Perspective: University of Pennsylvania Oral Cancer Screening School of Dental Medicine www.dental.upenn.edu by faizan alawi, dds Dean denis f. kinane, bds, phd 8 Facilities Update, TWO THUMBS UP! NEW ENDODONTIC CLINIC Master Plan Spotlight ON TRACK FOR EARLY 2013 OPENING, Associate Dean for Development PAGE 8. and Alumni Relations by beth adams maren gaughan Director, Publications 10 Answering the Call to beth adams Higher Education Contributing Writers by juliana delany Departments beth adams katherine unger baillie juliana delany 17 On Campus: News and People debbie goldberg 25 Scholarly Activity Design 28 Philanthropy Highlights dyad communications 29 Philanthropy Honor Roll Photography mark garvin 37 Alumni: News peter olson 41 Class Notes Penn Dental Journal is published twice a year for the alumni and friends of the 44 In Memoriam University of Pennsylvania School of Dental Medicine. ©2012 by the Trustees of the University of Pennsylvania. All rights reserved. We would like to get your feed - ALUMNI WEEKEND 2012 WELCOMED REUNION back and input on the Penn Dental Journal CLASSES ENDING IN “2” AND “7”, PAGE 38.
    [Show full text]
  • Spring 2009 Issue Feature Stories Include
    Penn Dental Journal For the University of Pennsylvania School of Dental Medicine Community / Spring 2009 features Bringing Da Vinci to Dentistry: School Opens State-of-the-Art CAD/CAM Ceramic Center | page 2 Oral Health, Cancer, and the Quality of Life: A Powerful Partnership with Abramson Cancer Center | page 6 A Global Perspective: Penn Dental Medicine Extending International Reach for Students, Scholars | page 10 in this issue Features 2 Bringing Da Vinci to Dentistry by jennifer baldino bonett 6 Oral Health, Cancer, THE NEW PENN DENTAL MEDICINE CAD/CAM CERAMIC CENTER FEATURES THE MOST and the Quality of Life PROMINENT CAD/CAM SYSTEMS ON THE by juliana delany MARKET AND A STATE-OF-THE-ART LABORATORY, PAGE 2. Penn Dental Journal 10 A Global Perspective Vol. 5, No. 2 by debbie goldberg Departments University of Pennsylvania School of Dental Medicine www.dental.upenn.edu 16 On Campus: News and People Interim Dean 28 Scholarly Activity thomas p. sollecito, dmd 30 Alumni: News and Class Notes Director, Publications beth adams 35 In Memoriam Contributing Writers beth adams amy biemiller jennifer baldino bonett juliana delany alandress gardner debbie goldberg Design dyad communications Photography PENN DENTAL MEDICINE CONTINUES candace dicarlo TO EXTEND ITS INTERNATIONAL REACH mark garvin THROUGH EFFORTS LIKE VISITING peter olson SCHOLARS PROGRAMS AND STUDENT DR. DENIS F. KINANE EXCHANGE, PAGE 10. HAS BEEN Penn Dental Journal is published twice a NAMED THE NEXT year for the alumni and friends of the University of Pennsylvania School of DEAN OF PENN Dental Medicine. ©2009 by the Trustees of DENTAL MEDICINE, the University of Pennsylvania.
    [Show full text]
  • Infographic. COVID-19 RT-PCR Testing for Elite Athletes
    Infographic Br J Sports Med: first published as 10.1136/bjsports-2020-103751 on 17 January 2021. Downloaded from Infographic. COVID-19 RT- PCR testing for elite athletes Alan Rankin ,1,2 Andrew Massey ,3 Éanna Cian Falvey ,4,5 Todd Ellenbecker,6 Peter Harcourt,7 Andrew Murray ,8,9 Denis Kinane,10 Bert Niesters,11 Nigel Jones,12 Rhodri Martin,13,14 Michael Roshon,15 Michael Edmund David McLarnon ,16 James Calder,17 Dionisio Izquierdo,18 Babette M Pluim ,19,20 Niall Elliott ,21 Neil Heron 22 http://bjsm.bmj.com/ on September 29, 2021 by guest. Protected copyright. This infographic outlines evidence-based implementation and interpretation of COVID-19 AND RT-PCR TESTING recommendations on COVID-19 reverse testing. The current gold standard of testing is transcriptase PCR (RT- PCR) testing in RT- PCR testing.4–6 The test is highly elite sport settings, aiming to protect sensitive and specific to SARS- CoV-2 personal and population health, and PREVENTION IS BEST viral RNA in laboratory conditions.2 Test acknowledging resources and expertise Interventions to prevent COVID-19 trans- results should be interpreted on the basis that are often available in elite sport. mission should be implemented consis- of the pretest probability, previous test Public health recommendations vary by tently1 2 and should include results and clinical history. Test sensi- country and region, and protocol deci- ► Effective hand hygiene. tivity and specificity will rely on the (1) sions should be made in consultation ► Physical distancing: athletes should quality and location of swabbing; (2) with relevant public health authorities.
    [Show full text]
  • Mailing Address School of Dentistry University of Louisville Louisville, Kentucky 40202
    2010-2011 Mailing Address School of Dentistry University of Louisville Louisville, Kentucky 40202 Location Health Sciences Center 501 South Preston Street Telephone Dean’s Office: 502-852-5295 Fax: 502-852-3364 Student Affairs: 502-852-5081 Fax: 502-852-1210 Registrar’s Office Belknap Campus: 502-852-6522 School of Dentistry: 502-852-1207 TABLE OF CONTENTS General Information Additional School of Dentistry Educational Academic Calendar Opportunities Directory Dental Hygiene Program Map of Health Sciences Center Note: Dental Hygiene is included in the University Message from the Dean Consolidated Catalog Health Sciences Center DMD Courses School of Dentistry Departments of Instruction Mission and Goals Basic Sciences Departments and Courses The University and the Community Department of Anatomical Sciences and Drug-Free Schools Notice Neurobiology Department of Biochemistry and Molecular Admission Information for the School of Biology Dentistry Department of Microbiology & Immunology Fees and Expenses Department of Pharmacology & Toxicology Classification of Residency Department of Physiology & Biophysics Financial Aid Accommodations and Services School of Dentistry Departments and Courses Department of General Dentistry and Oral Students Medicine Organizations Molecular, Cellular, and Craniofacial Biology Activities Department of Orthodontic, Pediatric Dentistry, Honors & Awards and Special Care Department of Oral Health and Rehabilitation Programs in Dentistry Department of Surgical & Hospital Dentistry Doctor of Dental Medicine (D.M.D.)
    [Show full text]